> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Medical Device Nitinol Increases Bench Testing: Analysis
- URL: https://www.fdaweb.com/medical-device-nitinol-increases-bench-testing-analysis/
- Published: 2020-10-29T12:00:00.000Z
- Updated: 2026-09-14T16:34:35.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5147979

Attorney **Michael Kasser** (Hogan Lovells) says that the use of nitinol by medical device manufacturers “significantly increases the amount of bench testing that will be required to obtain marketing clearance.” In an online [post](https://www.engage.hoganlovells.com/knowledgeservices/viewContent.action?key=Ec8teaJ9Vap5daGYBm776cxgHJMKLFEppVpbbVX%2B3OXcP3PYxlq7sZUjdbSm5FIetvAtgf1eVU8%3D&nav=FRbANEucS95NMLRN47z%2BeeOgEFCt8EGQ0qFfoEM4UR4%3D&emailtofriendview=true&freeviewlink=true&ref=fdaweb.com), Kasser says a recently finalized FDA [guidance](https://www.fdaweb.com/technical-considerations-for-devices-with-nitinol/) on medical devices that contain nitinol details the corrosion testing that has been common FDA practice and also significantly expands the type and amount of mechanical and characterization tests that will be required.

“As these tests typically need to be performed on final, finished devices, most of the testing burden will fall on the medical device company, not the material supplier,” Kasser says. “Accordingly, use of nitinol in medical devices should be avoided unless its unique material properties (superelasticity and/or shape memory) are critical to device function.”